Cryopreservation Calculators

0 calculators tagged with “Cryopreservation”

Cryopreservation preserves biological material — cells, tissues, embryos, and gametes — at very low temperatures, typically in liquid nitrogen at −196°C, where biological processes essentially stop. Successful cryopreservation requires cryoprotectants to prevent lethal ice crystal formation, controlled cooling rates, and proper thawing procedures. It is fundamental to biobanking, reproductive medicine, cell therapy manufacturing, and long-term storage of research cell lines. The two main strategies are slow controlled-rate freezing and vitrification, which uses ultra-rapid cooling to produce a glass-like amorphous state.

All Calculators

No calculators found for this topic.

Ice Crystal Damage and Cryoprotection

The main threat during freezing is intracellular ice crystal formation, which punctures membranes and destroys organelles. Cryoprotectants (CPAs) prevent this by lowering the freezing point, replacing intracellular water, and promoting vitrification of remaining water at sufficient concentrations. All CPAs involve a trade-off between cryoprotection and cytotoxicity.

Common Cryoprotectants

  • DMSO (10% v/v): Standard for most mammalian cells; penetrates membranes; cytotoxic at room temperature — add on ice and wash out immediately after thaw
  • Glycerol (10–20%): Used for red blood cells and sperm; slower membrane penetration
  • Trehalose: Non-penetrating CPA for surface stabilization; used for erythrocytes

Controlled-Rate Freezing

Standard protocol: suspend cells in freezing medium (10% DMSO in complete medium or FBS), cool at −1°C/min from 4°C to −80°C using a controlled-rate freezer or isopropanol-filled box (Mr. Frosty), then transfer to liquid nitrogen. The −1°C/min rate allows controlled extracellular ice formation that draws water out osmotically, protecting against intracellular ice while limiting dehydration stress.

Vitrification

Vitrification uses very high CPA concentrations (30–50%) and ultra-rapid cooling (>1000°C/min) to convert all cellular water directly into an amorphous glass with no ice crystals. It is the gold standard for embryos and oocytes in reproductive medicine, achieving >90% post-thaw viability. The main challenge is balancing CPA cryoprotection against cytotoxicity at high concentrations.

Glossary

Cryoprotectant (CPA)
A substance that protects cells during freezing by preventing ice crystal formation; DMSO and glycerol are most common; all CPAs trade cryoprotection against cytotoxicity.
Vitrification
Ultra-rapid cryopreservation using high CPA concentrations that converts cellular water directly to amorphous glass, avoiding ice crystals; gold standard for embryo and oocyte banking.
Controlled-Rate Freezing
Cryopreservation method that cools cells at −1°C/min to −80°C before liquid nitrogen storage; balances extracellular ice formation with cell dehydration to minimize intracellular ice.

Frequently Asked Questions

Standard protocol: (1) Grow cells to exponential phase with >90% viability. (2) Pellet, resuspend in ice-cold freezing medium: 90% FBS + 10% DMSO or complete medium + 10% DMSO. (3) Aliquot into cryovials on ice. (4) Cool at −1°C/min from 4°C to −80°C using a controlled-rate freezer or isopropanol Mr. Frosty box. (5) Transfer to liquid nitrogen vapor phase for long-term storage. Thaw rapidly at 37°C and dilute out DMSO immediately before use.

DMSO at 10% v/v penetrates cell membranes, replacing intracellular water and preventing lethal ice crystal formation. It lowers the freezing point and promotes vitrification of remaining cellular water. However, DMSO is toxic at room temperature — cells must be cooled immediately after addition, and DMSO must be washed out right after thawing in warm medium. Some cell therapy products limit DMSO dose to minimize patient toxicity during infusion.

Slow (controlled-rate) freezing cools cells at −1°C/min, allowing extracellular ice to form gradually and draw water out of cells osmotically, reducing intracellular ice. Uses 5–10% CPA. Some ice is always present extracellularly. Vitrification uses very high CPA concentrations (30–50%) and ultra-rapid cooling (>1000°C/min) to convert all water to an amorphous glass — no ice crystals form anywhere. Vitrification gives superior results for embryos and oocytes but requires precise CPA toxicity management.

At −196°C, biological aging and chemical reactions essentially stop — cells can theoretically remain viable indefinitely. Cell lines have been revived successfully after 20–30+ years of storage. The main practical risks are: liquid nitrogen depletion causing temperature rise above the glass transition temperature (−130°C), which allows recrystallization and cell death; and container failure. Vapor-phase nitrogen storage at −150°C to −160°C minimizes cross-contamination risk compared to liquid-phase storage.